Treatment of lymphocytic thyroiditis with spontaneously resolving hyperthyroidism (silent thyroiditis).

Area of Science:

• Endocrinology
• Internal Medicine
• Thyroidology

Background:

• Lymphocytic thyroiditis (LT) can present with spontaneously resolving hyperthyroidism (SRH).
• The optimal management of SRH in LT requires further investigation.
• Limited data exists on the efficacy of various treatments for SRH.

Purpose of the Study:

• To evaluate the duration of hyperthyroidism in patients with LT-SRH under different therapeutic regimens.
• To assess the effectiveness of prednisone, propylthiouracil, and propranolol in managing SRH.
• To investigate the role of thyroid hormone suppression therapy in preventing SRH recurrence.

Main Methods:

• Serial monitoring of thyroxine levels in patients with LT-SRH.
• Comparison of treatment groups: no treatment (control), propylthiouracil/propranolol, and prednisone.
• Observation of patients receiving thyroid hormone suppression therapy and those undergoing subtotal thyroidectomy.

Main Results:

• Prednisone therapy dramatically reduced the duration of hyperthyroidism (15 ± 7 days) compared to controls (57 ± 17 days).
• Propylthiouracil and/or propranolol showed no significant effect on hyperthyroidism duration (45 ± 13 days).
• Thyroid hormone suppression therapy was ineffective in preventing SRH episodes in five patients.

Conclusions:

• Prednisone is an effective treatment for shortening the duration of hyperthyroidism in LT-SRH.
• Propylthiouracil and propranolol offer limited benefit for SRH in this context.
• Thyroid hormone suppression therapy may not prevent recurrent SRH, and subtotal thyroidectomy is an option for refractory cases.